Amnis Therapeutics
Endovascular Technologies for Emergency Situations
Company Overview
Snapshot
Founded in January 2007, Amnis Therapeutics operates with 1–10 employees. The company has raised a total of $400K across two funding rounds, with MedTech Innovator as an investor.
Business overview
Amnis Therapeutics is a biomedical engineering company that develops, manufactures, and markets lifesaving endovascular technologies for emergency situations. The company's core products include AneugraftDx, a pericardium covered coronary stent for emergency vessel reconstruction, and AneugraftNx, a neurovascular pericardium covered stent for intracranial indications. Additionally, Amnis Therapeutics offers the Golden Retriever, a mechanical neurothrombectomy device for acute ischemic stroke. The company serves the medical community by providing innovative, high-performance devices for numerous endovascular indications within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices, Medical Treatment & Therapeutics, and Life Support.
Strategic signal
In January 2017, Amnis Therapeutics initiated its first clinical trial for its neuro thrombectomy device. This milestone indicates the company's progression from product development to clinical validation, signaling a critical step towards market readiness and potential commercialization for its innovative neurovascular solutions.
Company Intelligence Q&A
- What is Amnis Therapeutics' primary focus?
- Amnis Therapeutics specializes in developing, manufacturing, and marketing lifesaving endovascular technologies designed for emergency situations, providing innovative devices for various endovascular indications.
- When did Amnis Therapeutics cease operations?
- Amnis Therapeutics ceased to operate in July 2021.
- What is the AneugraftDx product?
- The AneugraftDx is a pericardium covered coronary stent developed by Amnis Therapeutics for emergency vessel reconstruction in cases of acute rupture or dissection of a coronary artery, coronary aneurysm, or saphenous vein graft reperfusion.
- What is the Golden Retriever product?
- The Golden Retriever is a mechanical neurothrombectomy device developed by Amnis Therapeutics for the emergency treatment of acute ischemic stroke.